RILEXINE- cephalexin tablet, chewable

Country: United States

Language: English

Source: NLM (National Library of Medicine)

Active ingredient:

cephalexin (UNII: OBN7UDS42Y) (CEPHALEXIN ANHYDROUS - UNII:5SFF1W6677)

Available from:

Virbac AH, Inc

INN (International Name):

cephalexin

Composition:

cephalexin 150 mg

Administration route:

ORAL

Prescription type:

PRESCRIPTION

Therapeutic indications:

RILEXINE Chewable Tablets are contraindicated in dogs with a known allergy to cephalexin or to the β-lactam (any of the penicillins or cephalosporins) group of antibiotics. 

Product summary:

RILEXINE (cephalexin tablets) Chewable Tablets are supplied in 150 mg, 300 mg, and 600 mg tablets packaged in bottles of 100 tablets.

Authorization status:

New Animal Drug Application

Summary of Product characteristics

RILEXINE- CEPHALEXIN TABLET, CHEWABLE
VIRBAC AH, INC
----------
RILEXINE®
(CEPHALEXIN TABLETS)
CHEWABLE TABLETS
Antimicrobial for Oral Use in Dogs only.
CAUTION
Federal (USA) law restricts this drug to use by or on the order of a
licensed veterinarian.
DESCRIPTION
RILEXINE® Chewable Tablets are a chewable, bisected tablet supplied
in 3 sizes
containing 150 mg, 300 mg, and 600 mg of cephalexin. Cephalexin is a
cephalosporin,
beta-lactam, broad spectrum antibiotic. The full chemical name for
cephalexin is 7-(D-
aamino-a-phenylacetamido)-3-methyl-3-cephem-4-carboxylic acid
monohydrate.
INDICATION
For the treatment of secondary superficial bacterial pyoderma in dogs
caused by
susceptible strains of _Staphylococcus pseudintermedius._
DOSAGE AND ADMINISTRATION
The recommended dose is 22 mg/kg (10 mg/lb) of body weight twice daily
for 28 days.
Appropriate culture and susceptibility tests should be performed
before treatment to
determine the causative organism and its susceptibility to cephalexin.
Therapy with
RILEXINE Chewable Tablets may be initiated before results of these
tests are known;
once the results become available, antimicrobial therapy should be
adjusted accordingly.
If acceptable response to treatment is not observed, then the
diagnosis should be
reevaluated and appropriate alternative therapy considered.
CONTRAINDICATIONS
RILEXINE Chewable Tablets are contraindicated in dogs with a known
allergy to
cephalexin or to the β-lactam (any of the penicillins or
cephalosporins) group of
antibiotics.
WARNINGS
For use in dogs only. Not for use in humans. Keep this drug out of the
reach of children.
Antimicrobials, including penicillins and cephalosporins, can cause
allergic reactions in
sensitized individuals. Sensitized individuals handling such
antimicrobials, including
cephalexin, should avoid contact of the product with the skin and
mucous membranes
in order to minimize the risk of allergic reactions.
In case of ingestion by humans contact a physician immediately.
Physicians may contact
a poison control cente